Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Resources from ESMO Colloquia

ESMO-TAT-2025-1000x1000

The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.

04/03/2025

ESMO Colloquium supported by Novartis: 
Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation

Watch session

  • Welcome and introduction
    Alessandra Gennari
  • Clinical drug development of radiotheranostics: Trial design, administered vs absorbed dose and the role of internal dosimetry
    Alessandra Gennari
  • Current policy and regulatory hurdles for RLT implementation: Regulatory approval, centre accreditation and radioprotection, reimbursement
    Valentina Di Iorio
  • Q&A and discussion

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.